IP Library Granted Patent US 9,068,017
Granted Patent B2
US 9,068,017 · App. 13/081,272 · Granted Jun 30, 2015

Compositions and methods for inhibiting terminal transferase activity

Inventors: Sherilynn Manalili Wheeler (Encinitas, CA); James C. Hannis (Vista, CA); Steven A. Hofstadler (Vista, CA)
Assignee: IBIS BIOSCIENCES, INC.
C07K14/5406C07K14/4703C12Q1/686
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,068,017
App. No.
13/081,272
Granted
Jun 30, 2015
Kind
B2
Abstract

The present invention relates to systems and methods for amplifying nucleic acid. In particular, systems and methods are provided for inhibiting polymerase based terminal transferase activity within a polynucleotide amplification setting (e.g., polymerase chain reaction). In addition, systems and methods are provided for generating amplified products generated with polynucleotide amplification techniques having reduced 3′ non-templated nucleotide addition.

Claims (28)

1. A method for generating amplification products, comprising: a) combining boric acid and a reaction solution comprising a nucleic acid template, primers complementary to the nucleic acid template, deoxynucleotide triphosphates, a polymerase having terminal transferase activity and a buffer solution comprising KCl and Tris-HCl; and b) performing a polymerase chain (PCR) with said combined boric acid and said reaction solution such that amplification products are generated.

2. The method of claim 1 , wherein said polymerase having terminal transferase activity is Taq polymerase or a fragment thereof.

3. The method of claim 1 , further comprising the step of detecting said amplification products via mass spectroscopy.

4. The method of claim 1 , wherein said reaction solution further comprises divalent cations.

5. The method of claim 4 , wherein said divalent cations are selected from the group consisting of Mg 2+ and Mn 2 + divalent cations.

6. The method of claim 1 , further comprising the step of analyzing said generated amplification product.

7. The method of claim 6 , wherein said analyzing comprises the use of mass spectroscopy.

8. A method for generating amplification products, comprising: a) combining boric acid and a reaction solution comprising a nucleic acid template, primers complementary to the nucleic acid template, deoxynucleotide triphosphates, a polymerase having terminal transferase activity and a buffer solution comprising (NH) 4 SO 4 and Tris-HCl; and b) performing a polymerase chain (PCR) with said combined boric acid and said reaction solution such that amplification products are generated.

9. The method of claim 8 , wherein said polymerase having terminal transferase activity is Taq polymerase or a fragment thereof.

10. The method of claim 8 , further comprising the step of detecting said amplification products via mass spectroscopy.

11. The method of claim 8 , wherein said reaction solution further comprises divalent cations.

12. The method of claim 11 , wherein said divalent cations are selected from the group consisting of Mg 2+ and Mn 2+ divalent cations.

13. The method of claim 8 , further comprising the step of analyzing said generated amplification product.

14. The method of claim 13 , wherein said analyzing comprises the use of mass spectroscopy.

15. A method for generating amplification products, comprising: a) combining boric acid and a reaction solution comprising a nucleic acid template, primers complementary to the nucleic acid template, deoxynucleotide triphosphates, a polymerase having terminal transferase activity wherein said boric acid is present at a final concentration of 100 mM to 200 mM in said reaction solution; and b) performing a polymerase chain (PCR) with said combined boric acid and said reaction solution such that amplification products are generated.

16. The method of claim 15 , wherein said polymerase having terminal transferase activity is Taq polymerase or a fragment thereof.

17. The method of claim 15 , further comprising the step of detecting said amplification products via mass spectroscopy.

18. The method of claim 15 , wherein said reaction solution further comprises divalent cations.

19. The method of claim 18 , wherein said divalent cations are selected from the group consisting of Mg 2+ and Mn 2+ divalent cations.

20. The method of claim 15 , further comprising the step of analyzing said generated amplification product.

21. The method of claim 20 , wherein said analyzing comprises the use of mass spectroscopy.

22. A method for generating amplification products, comprising: a) combining boric acid and a reaction solution comprising a nucleic acid template, primers complementary to the nucleic acid template, deoxynucleotide triphosphates, a polymerase having terminal transferase activity wherein said boric acid is present at a final concentration of 50 mM to 500 mM in said reaction solution; and b) performing a polymerase chain (PCR) with said combined boric acid and said reaction solution such that amplification products are generated.

23. The method of claim 22 , wherein said polymerase having terminal transferase activity is Taq polymerase or a fragment thereof.

24. The method of claim 22 , further comprising the step of detecting said amplification products via mass spectroscopy.

25. The method of claim 22 , wherein said reaction solution further comprises divalent cations.

26. The method of claim 25 , wherein said divalent cations are selected from the group consisting of Mg 2+ and Mn 2+ divalent cations.

27. The method of claim 22 , further comprising the step of analyzing said generated amplification product.

28. The method of claim 27 , wherein said analyzing comprises the use of mass spectroscopy.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 4, 2012
From: MANALILI-WHEELER, SHERILYNN; HANNIS, JAMES C.; HOFSTADLER, STEVEN A.
To: IBIS BIOSCIENCES, INC.
Reel/Frame 027987/0682 →
Continuity (2)
Provisional Application 61322195 · Apr 8, 2010
Related Publication 20110250648A1 · Oct 13, 2011